Eye Melanoma Market Research Report Information By Site (Sclera, Retina, Uvea), By Diagnosis (Eye Exam, Imaging, Biopsy), Treatment (Radiation Therapy, Laser Treatment, Surgery), End User (Hospitals & Clinics, Academic Institutes) - Global Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Eye Melanoma Market, By Site

6.1 Introduction

6.2 Sclera

Market Estimates & Forecast, 2023 – 2030

6.3 Retina

Market Estimates & Forecast, 2023 – 2030

6.4 Uvea

Market Estimates & Forecast, 2023 – 2030

Chapter 7. Global Eye Melanoma Market, By Diagnosis

7.1 Introduction

7.2 Eye Exam

Market Estimates & Forecast, 2023 – 2030

7.2.1 Ophthalmoscopy

7.2.2 Slit-Lamp Biomicroscopy

7.2.3 Others

7.3 Imaging

Market Estimates & Forecast, 2023 – 2030

7.3.1 Ultrasound

7.3.2 Fluorescein Angiography

7.3.3 Fundus Autofluorescence

7.3.4 Optical Coherence Tomography

7.3.5 Others

7.4 Biopsy

Market Estimates & Forecast, 2023 – 2030

7.5 Others

Chapter 8. Global Eye Melanoma Market, By Treatment

8.1 Introduction

8.2 Radiation Therapy

Market Estimates & Forecast, 2023 – 2030

8.2.1 Episcleral Plaque Therapy

8.2.2 External Beam Radiation Therapy

8.2.2.1 Computed Tomography (CT)

8.2.2.2 Positron Emission Tomography (PET)

8.2.2.3 Others

8.3 Laser Treatment

Market Estimates & Forecast, 2023 – 2030

8.4 Surgery

Market Estimates & Forecast, 2023 – 2030

8.4.1 Iridectomy

8.4.2 Choroidectomy

8.4.3 Enucleation

8.4.4 Others

Chapter 9 Global Eye Melanoma Market, By End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2023 – 2030

9.3 Academic Institutes

Market Estimates & Forecast, 2023 – 2030

9.4 Others

Chapter 10. Global Eye Melanoma Market, By Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Castle Biosciences, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 GENERAL ELECTRIC

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Koninklijke Philips N.V.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 TOSHIBA CORPORATION

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Siemens AG

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Analogic Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Optovue, Incorporated

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 NOVADAQ Technologies Inc.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Agfa-Gevaert Group

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 ZEISS

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Pharmaceutical Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Eye Melanoma Industry Synopsis, 2023 – 2030

Table 2 Global Eye Melanoma Market Estimates And Forecast, 2023 – 2030, (USD Million)

Table 3 Global Eye Melanoma Market By Region, 2023 – 2030, (USD Million)

Table 4 Global Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 5 Global Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 6 Global Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 7 Global Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 8 North America Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 9 North America Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 10 North America Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 11 North America Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 12 US Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 13 US Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 14 US Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 15 US Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 16 Canada Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 17 Canada Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 18 Canada Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 19 Canada Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 20 South America Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 21 South America Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 22 South America Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 23 South America Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 24 Europe Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 25 Europe Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 26 Europe Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 27 Europe Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 28 Western Eye Melanoma Europe Market By Site, 2023 – 2030, (USD Million)

Table 29 Western Europe Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 30 Western Europe Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 31 Western Europe Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 32 Eastern Europe Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 33 Eastern Europe Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 34 Eastern Europe Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 35 Eastern Europe Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 36 Asia Pacific Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 37 Asia Pacific Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 38 Asia Pacific Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 39 Asia Pacific Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

Table 40 Middle East & Africa Eye Melanoma Market By Site, 2023 – 2030, (USD Million)

Table 41 Middle East & Africa Eye Melanoma Market By Diagnosis, 2023 – 2030, (USD Million)

Table 42 Middle East & Africa Eye Melanoma Market By Treatment, 2023 – 2030, (USD Million)

Table 43 Middle East & Africa Eye Melanoma Market By End User, 2023 – 2030, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Eye Melanoma Market

Figure 3 Segmentation Market Dynamics For Global Eye Melanoma Market

Figure 4 Global Eye Melanoma Market Share, By Site 2023

Figure 5 Global Eye Melanoma Market Share, By Diagnosis 2023

Figure 6 Global Eye Melanoma Market Share, By Treatment 2023

Figure 7 Global Eye Melanoma Market Share, By End User, 2023

Figure 8 Global Eye Melanoma Market Share, By Region, 2023

Figure 9 North America Eye Melanoma Market Share, By Country, 2023

Figure 10 Europe Eye Melanoma Market Share, By Country, 2023

Figure 11 Asia Pacific Eye Melanoma Market Share, By Country, 2023

Figure 12 Middle East & Africa Eye Melanoma Market Share, By Country, 2023

Figure 13 Global Eye Melanoma Market: Company Share Analysis, 2023 (%)

Figure 14 Castle Biosciences, Inc.: Key Financials

Figure 15 Castle Biosciences, Inc.: Segmental Revenue

Figure 16 Castle Biosciences, Inc.: Geographical Revenue

Figure 17 GENERAL ELECTRIC: Key Financials

Figure 18 GENERAL ELECTRIC: Segmental Revenue

Figure 19 GENERAL ELECTRIC: Geographical Revenue

Figure 20 Koninklijke Philips N.V.: Key Financials

Figure 21 Koninklijke Philips N.V.: Segmental Revenue

Figure 22 Koninklijke Philips N.V.: Geographical Revenue

Figure 23 TOSHIBA CORPORATION: Key Financials

Figure 24 TOSHIBA CORPORATION: Segmental Revenue

Figure 25 TOSHIBA CORPORATION: Geographical Revenue

Figure 26 Siemens AG: Key Financials

Figure 27 Siemens AG: Segmental Revenue

Figure 28 Siemens AG: Geographical Revenue

Figure 29 Analogic Corporation:Key Financials

Figure 30 Analogic Corporation: Segmental Revenue

Figure 31 Analogic Corporation: Geographical Revenue

Figure 32 Optovue, Incorporated: Key Financials

Figure 33 Optovue, Incorporated: Segmental Revenue

Figure 34 Optovue, Incorporated: Geographical Revenue

Figure 35 NOVADAQ Technologies Inc.: Key Financials

Figure 36 NOVADAQ Technologies Inc.: Segmental Revenue

Figure 37 NOVADAQ Technologies Inc.: Geographical Revenue

Figure 38 Agfa-Gevaert Group: Key Financials

Figure 39 Agfa-Gevaert Group: Segmental Revenue

Figure 40 Agfa-Gevaert Group: Geographical Revenue

Figure 41 ZEISS: Key Financials

Figure 42 ZEISS: Segmental Revenue

Figure 43 ZEISS: Geographical Revenue